01
Market Access & Trade Development
Opening pharmaceutical trade routes across CARICOM, Latin America, Africa, and the Global South.
Saber maisWho We Are
Established to bring access to essential medicines to Barbadians, the Caribbean and beyond
About BPI
In 2020, the COVID-19 pandemic exposed what small island states already knew: when global supply chains fracture, the Caribbean waits longest and receives least. Barbados imported almost all the medicines its population needed.
That dependency cost the country during the pandemic and continues to do so today.
Barbados Pharmaceutical Inc. was established in 2023 by the Government of Barbados, operating under the Ministry of Health and Wellness, to address that structural vulnerability directly. BPI's mandate is to develop the pharmaceutical ecosystem needed to attract investment, build local manufacturing capacity, and position Barbados as a production and distribution hub for CARICOM and beyond.
Our Vision
By 2035, Barbados will be a trusted regional hub for high-quality pharmaceutical manufacturing, life sciences innovation, and regulatory excellence, advancing equitable access to essential medicines across the Caribbean and the Global South.
Manufacture
Local production of essential medicines, starting with IV fluids, scaling to ARVs, diagnostics, and for NCDs.
Distribute
A regional hub logistics model that puts medicines where they're needed, faster and cheaper.
Build
The regulatory, workforce, and institutional foundations that sustain a pharmaceutical sector for generations.
BPI is a market creator
What We Are BuildingA Market Facilitator, Not Just an Agency
BPI is a market creator. Our role is a sector accelerator and investment facilitator, catalyzing investment, partnerships, manufacturing, and policy alignment, serving as a gateway to global demand and creating new market entry points. Through a catalytic project incubator model, we’re pushing from investment to impact.
The Difference We Make
97% of Caribbean medicines are imported today. BPI exists to change that, one shipment, one facility, one policy at a time
Our Mission
To accelerate equitable access to high-quality, affordable medicines and health products by catalyzing the development of a resilient and competitive pharmaceutical industry, positioning Barbados as a gateway to the Caribbean and beyond, through strategic partnerships, investment facilitation, and regional collaboration.
By The Numbers
BPI is building a globally competitive pharmaceutical ecosystem that will create jobs, attract investment, and expand access to essential medicines across the Caribbean.
- Projected high-value jobs created during the first phase of Barbados’ pharmaceutical sector development.
- CARICOM markets targeted for regional supply through Barbados-based manufacturing and distribution.
- Pharmaceutical manufacturers targeted within the first five years, supported by a coordinated ecosystem for regulation, workforce, R&D and investment.
Our Team
BPI is led by a team of global health strategists, investment specialists, and pharmaceutical sector experts united by a single mandate.
Dr. Cindi Lewis
Chief Executive Officer A.g.
Linga Kalinde Mangachi
Senior Portfolio Project Manager
Kurt Gielen
Senior Business Development Officer, Europe
Dr. Laura-Mae Britton
Advisor, Strategy, Data & Innovation
Jocelyn Mackie
Innovative Financing Lead
Nakeba Mason
Senior Manager, Strategic Coordination
Debbie Skinner
Senior Administrative Assistant
Kimberley Skinner
Executive Assistant
Nicole Asinugo
Head of Strategic Communications
Iniye Spiff
Communications Officer
Build With Us
Careers
Every role at BPI contributes to building the pharmaceutical infrastructure that the Caribbean depends on. Join a team working at the intersection of government, investment, manufacturing, and regional health policy.
The gateway is open. Ready to build with us?
Deliberately. Piece by piece. With the people it is for. If you are a partner, investor, or government, we would like to build with you.
Partners
